Open AccessEfficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations
Author(s) -
Alexander Wong,
Deborah Goldstein,
Josép Mallolas,
Edwin DeJesus,
Margaret Johnson,
JeanMichel Molina,
Anton Pozniak,
Anthony Rodgers,
Valerie Teal,
Deborah A. Hepler,
Sushma Kumar,
Peter Sklar,
George J. Hanna,
Carey Hwang,
Cyrus Badshah,
Hedy Teppler
Publication year - 2019
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002153
Subject(s) - lamivudine , tenofovir , reverse transcriptase inhibitor , virology , medicine , human immunodeficiency virus (hiv) , resistance mutation , reverse transcriptase , emtricitabine , pharmacology , sida , chemistry , viral disease , virus , hepatitis b virus , polymerase chain reaction , biochemistry , gene